(Q43276188)

18 November 2017

1 reference

title

Chronic PDE-5 inhibition in patients with erectile dysfunction: new treatment approach using once daily Tadalafil (English)

1 reference

18 November 2017

1 reference

H Porst

1

1 reference

18 November 2017

K Hell-Momeni

series ordinal

2

1 reference

18 November 2017

H Büttner

series ordinal

3

1 reference

18 November 2017

language of work or name

German

0 references

publication date

1 November 2009

1 reference

18 November 2017

1 reference

18 November 2017

volume

48

1 reference

18 November 2017

issue

11

1 reference

18 November 2017

page(s)

1318, 1320-9

1 reference

The effects of chronic phosphodiesterase-5 inhibitor use on different organ systems

18 November 2017

cites work

1 reference

12 December 2020

Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trial

1 reference

12 December 2020

Randomized, double-blind, crossover trial of sildenafil in men with mild to moderate erectile dysfunction: efficacy at 8 and 12 hours postdose

1 reference

12 December 2020

Phosphodiesterase type 5 inhibitors' extended duration of response as a variable in the treatment of erectile dysfunction

1 reference

12 December 2020

Association between erectile dysfunction and coronary artery disease: Matching the right target with the right test in the right patient

1 reference

12 December 2020

An open-label, multicentre, randomized, crossover study comparing sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy

1 reference

12 December 2020

Quality of life and erectile dysfunction

1 reference

12 December 2020

Circulating endothelial progenitor cells and endothelial function after chronic Tadalafil treatment in subjects with erectile dysfunction

1 reference

12 December 2020

The phosphodiesterase-5 inhibitor tadalafil reduces myocardial infarct size

1 reference

12 December 2020

The efficacy of sildenafil citrate (Viagra) in clinical populations: an update

1 reference

12 December 2020

Brachial Artery Vasodilator Function and Systemic Inflammation in the Framingham Offspring Study

1 reference

12 December 2020

Long-term safety and tolerability of tadalafil in the treatment of erectile dysfunction

1 reference

12 December 2020

The prevalence and etiology of impotence in 101 male hypertensive outpatients

1 reference

12 December 2020

Erectile dysfunction and subsequent cardiovascular disease

1 reference

12 December 2020

[Tadalafil vs sildenafil patient preference in Spanish men with erectile dysfunction: results from an International Multicentric Study]

1 reference

12 December 2020

Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease

1 reference

12 December 2020

Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility

1 reference

12 December 2020

1 reference

12 December 2020

Efficacy and safety of daily tadalafil in men with erectile dysfunction previously unresponsive to on-demand tadalafil

1 reference

12 December 2020

Prospective, randomized, open-label, fixed-dose, crossover study to establish preference of patients with erectile dysfunction after taking the three PDE-5 inhibitors

1 reference

12 December 2020

The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial

1 reference

12 December 2020

Association of type and duration of diabetes with erectile dysfunction in a large cohort of men

1 reference

12 December 2020

Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses

1 reference

12 December 2020

Tadalafil dosed once a day in men with erectile dysfunction: a randomized, double-blind, placebo-controlled study in the US.

1 reference

12 December 2020

Comparable efficacy of once-daily versus on-demand vardenafil in men with mild-to-moderate erectile dysfunction: findings of the RESTORE study

1 reference

12 December 2020

Efficacy of tadalafil once daily in men with diabetes mellitus and erectile dysfunction

1 reference

12 December 2020

Evaluation of the efficacy and safety of once-a-day dosing of tadalafil 5mg and 10mg in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial.

1 reference

12 December 2020

Phosphodiesterase type 5 is not upregulated by tadalafil in cultures of human penile cells

1 reference

12 December 2020

Time course of the interaction between tadalafil and nitrates

1 reference

12 December 2020

Psychosocial outcomes and drug attributes affecting treatment choice in men receiving sildenafil citrate and tadalafil for the treatment of erectile dysfunction: results of a multicenter, randomized, open-label, crossover study

1 reference

12 December 2020

Screening for ischemic heart disease in patients with erectile dysfunction: role of penile Doppler ultrasonography

1 reference

12 December 2020

Chronic treatment with tadalafil improves endothelial function in men with increased cardiovascular risk

1 reference

12 December 2020

Extended Duration of Efficacy of Vardenafil When Taken 8 Hours Before Intercourse: A Randomized, Double-Blind, Placebo-Controlled Study

1 reference

12 December 2020

Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group

1 reference

12 December 2020

Ocular safety in patients using sildenafil citrate therapy for erectile dysfunction

1 reference

12 December 2020

Endothelial dysfunction links erectile dysfunction to heart disease

1 reference

12 December 2020

Comparison of efficacy, safety, and tolerability of on-demand tadalafil and daily dosed tadalafil for the treatment of erectile dysfunction

1 reference

12 December 2020

Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle.

1 reference

12 December 2020

Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence

1 reference

12 December 2020

Inflammation-induced endothelial dysfunction involves reduced nitric oxide bioavailability and increased oxidant stress

1 reference

12 December 2020

Vascular repair by circulating endothelial progenitor cells: the missing link in atherosclerosis?

1 reference

12 December 2020

Switching patients with erectile dysfunction from sildenafil citrate to tadalafil: results of a European multicenter, open-label study of patient preference

1 reference

12 December 2020

Comparison of phosphodiesterase type 5 (PDE5) inhibitors

1 reference

12 December 2020

Subclinical coronary artery atherosclerosis in patients with erectile dysfunction

1 reference

12 December 2020

Endothelial function and nitric oxide: clinical relevance

1 reference

12 December 2020

Unfavourable endothelial and inflammatory state in erectile dysfunction patients with or without coronary artery disease

1 reference

12 December 2020

Is erectile dysfunction the "tip of the iceberg" of a systemic vascular disorder?

1 reference

12 December 2020

Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use

1 reference

12 December 2020

Comparing vardenafil and sildenafil in the treatment of men with erectile dysfunction and risk factors for cardiovascular disease: a randomized, double-blind, pooled crossover study.

1 reference

12 December 2020

Update on clinical trials of tadalafil demonstrates no increased risk of cardiovascular adverse events

1 reference

12 December 2020

Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study

1 reference

12 December 2020

Long-term safety and efficacy of tadalafil 5 mg dosed once daily in men with erectile dysfunction

1 reference

12 December 2020

Tadalafil pharmacokinetics in healthy subjects

1 reference

12 December 2020

A multicenter, randomized, double-blind, crossover study of patient preference for tadalafil 20 mg or sildenafil citrate 50 mg during initiation of treatment for erectile dysfunction

1 reference

12 December 2020

Relationship between chronic tadalafil administration and improvement of endothelial function in men with erectile dysfunction: a pilot study

1 reference

12 December 2020

Efficacy and selectivity of phosphodiesterase-targeted drugs in inhibiting photoreceptor phosphodiesterase (PDE6) in retinal photoreceptors.

1 reference

12 December 2020

A multicenter, randomized, double-blind, crossover study to evaluate patient preference between tadalafil and sildenafil

1 reference

12 December 2020

10.1007/S00120-009-2089-Y

Identifiers

DOI

1 reference

18 November 2017

1 reference